Assyro AI

Orange Book product · Brand (NDA)

MORPHABOND ER

MORPHINE SULFATE

Brand (NDA)NDA 206544DISCN OHEMO LIFE

At a glance

Oct 02, 2015

Approved

Brand (NDA)

Application

Not listed

TE code

2

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Oct 02, 2015

    10 yr 10 mo ago

  2. Today

  3. Patent 10314788 expires

    Listed drug product patent expiration.

    Aug 12, 2028

    in 2 yr 2 mo

  4. Patent 7955619 expires

    Listed drug product patent expiration.

    Aug 12, 2028

    in 2 yr 2 mo

Pharmaceutical detail

Active ingredient

MORPHINE SULFATE

Strength

15MG

Dosage form

TABLET, EXTENDED RELEASE

Route

ORAL

TE code

Not listed

Application

NDA 206544

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

Yes

Reference standard (RS)

No

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (2)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
10314788Aug 12, 2028in 2 yr 2 mo
Product
7955619Aug 12, 2028in 2 yr 2 mo
Product
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.